AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,365,520 | -7.4% | 109,138 | +1.7% | 0.00% | 0.0% |
| Q1 2024 | $4,712,728 | -28.8% | 107,327 | +0.2% | 0.00% | -50.0% |
| Q4 2023 | $6,623,269 | +34.7% | 107,086 | +0.1% | 0.00% | 0.0% |
| Q3 2023 | $4,918,630 | -21.8% | 106,950 | -2.3% | 0.00% | 0.0% |
| Q2 2023 | $6,288,657 | +77.0% | 109,425 | +15.5% | 0.00% | +100.0% |
| Q1 2023 | $3,553,575 | +37.0% | 94,762 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $2,594,371 | +0.9% | 92,590 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $2,570,000 | -17.2% | 91,440 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $3,105,000 | -0.8% | 89,234 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $3,130,000 | +52.9% | 87,191 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $2,047,000 | +26.4% | 87,875 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $1,620,000 | +4.9% | 85,269 | +11.3% | 0.00% | 0.0% |
| Q2 2021 | $1,544,000 | -16.9% | 76,601 | -24.5% | 0.00% | 0.0% |
| Q1 2021 | $1,858,000 | -8.4% | 101,407 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $2,028,000 | +8.0% | 100,861 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $1,878,000 | -10.4% | 100,160 | +7.3% | 0.00% | 0.0% |
| Q2 2020 | $2,097,000 | +62.6% | 93,384 | +7.5% | 0.00% | 0.0% |
| Q1 2020 | $1,290,000 | -22.9% | 86,898 | +0.2% | 0.00% | 0.0% |
| Q4 2019 | $1,674,000 | +3.7% | 86,737 | +6.5% | 0.00% | 0.0% |
| Q3 2019 | $1,614,000 | -8.2% | 81,411 | -2.2% | 0.00% | 0.0% |
| Q2 2019 | $1,759,000 | +5.1% | 83,284 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $1,673,000 | +13.0% | 81,884 | +10.3% | 0.00% | 0.0% |
| Q4 2018 | $1,481,000 | +3.9% | 74,261 | +0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,425,000 | +29.5% | 74,224 | +3.6% | 0.00% | 0.0% |
| Q2 2018 | $1,100,000 | -10.2% | 71,656 | +9.1% | 0.00% | 0.0% |
| Q1 2018 | $1,225,000 | -3.0% | 65,680 | +0.1% | 0.00% | 0.0% |
| Q4 2017 | $1,263,000 | +7.4% | 65,586 | -0.3% | 0.00% | 0.0% |
| Q3 2017 | $1,176,000 | +1.5% | 65,812 | +1.4% | 0.00% | 0.0% |
| Q2 2017 | $1,159,000 | +35.4% | 64,901 | +10.1% | 0.00% | 0.0% |
| Q1 2017 | $856,000 | -21.4% | 58,974 | -0.3% | 0.00% | 0.0% |
| Q4 2016 | $1,089,000 | +94.1% | 59,128 | +99.4% | 0.00% | 0.0% |
| Q3 2016 | $561,000 | +516.5% | 29,649 | +420.6% | 0.00% | – |
| Q2 2016 | $91,000 | +31.9% | 5,695 | 0.0% | 0.00% | – |
| Q1 2016 | $69,000 | -14.8% | 5,695 | 0.0% | 0.00% | – |
| Q4 2015 | $81,000 | +28.6% | 5,695 | 0.0% | 0.00% | – |
| Q3 2015 | $63,000 | -36.4% | 5,695 | 0.0% | 0.00% | – |
| Q2 2015 | $99,000 | – | 5,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Summit Global Investments | 58,640 | $870,000 | 0.13% |
| FEDERATED HERMES, INC. | 2,600,120 | $38,586,000 | 0.11% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 284,328 | $4,219,000 | 0.07% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 291,352 | $4,324,000 | 0.05% |
| MARSHALL WACE, LLP | 301,910 | $4,481,000 | 0.04% |
| MARTINGALE ASSET MANAGEMENT L P | 212,817 | $3,159,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 171,266 | $2,542,000 | 0.03% |
| WINTON GROUP Ltd | 82,402 | $1,223,000 | 0.03% |
| EAGLE ASSET MANAGEMENT INC | 317,988 | $4,718,000 | 0.03% |
| Engineers Gate Manager LP | 24,007 | $356,000 | 0.03% |